Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

196 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effect of adding gefitinib to neoadjuvant chemotherapy in estrogen receptor negative early breast cancer in a randomized phase II trial.
Bernsdorf M, Ingvar C, Jörgensen L, Tuxen MK, Jakobsen EH, Saetersdal A, Kimper-Karl ML, Kroman N, Balslev E, Ejlertsen B. Bernsdorf M, et al. Among authors: kroman n. Breast Cancer Res Treat. 2011 Apr;126(2):463-70. doi: 10.1007/s10549-011-1352-2. Epub 2011 Jan 15. Breast Cancer Res Treat. 2011. PMID: 21234672 Clinical Trial.
[Treatment of elderly patients with breast cancer].
Paaschburg B, Pedersen A, Tuxen MK, Nielsen MM, Kroman N. Paaschburg B, et al. Among authors: kroman n. Ugeskr Laeger. 2008 Mar 31;170(14):1133-8. Ugeskr Laeger. 2008. PMID: 18405474 Review. Danish.
Population-based study of peritumoral lymphovascular invasion and outcome among patients with operable breast cancer.
Ejlertsen B, Jensen MB, Rank F, Rasmussen BB, Christiansen P, Kroman N, Kvistgaard ME, Overgaard M, Toftdahl DB, Mouridsen HT; Danish Breast Cancer Cooperative Group. Ejlertsen B, et al. Among authors: kroman n. J Natl Cancer Inst. 2009 May 20;101(10):729-35. doi: 10.1093/jnci/djp090. Epub 2009 May 12. J Natl Cancer Inst. 2009. PMID: 19436035
Value of post-operative reassessment of estrogen receptor α expression following neoadjuvant chemotherapy with or without gefitinib for estrogen receptor negative breast cancer.
Bernsdorf M, Balslev E, Lykkesfeldt AE, Kroman N, Harder E, von der Maase H, Jakobsen EH, Grabau D, Ejlertsen B. Bernsdorf M, et al. Among authors: kroman n. Breast Cancer Res Treat. 2011 Jul;128(1):165-70. doi: 10.1007/s10549-011-1535-x. Epub 2011 Apr 23. Breast Cancer Res Treat. 2011. PMID: 21516302 Clinical Trial.
Mortality rates among early-stage hormone receptor-positive breast cancer patients: a population-based cohort study in Denmark.
Christiansen P, Bjerre K, Ejlertsen B, Jensen MB, Rasmussen BB, Lænkholm AV, Kroman N, Ewertz M, Offersen B, Toftdahl DB, Møller S, Mouridsen HT; Danish Breast Cancer Cooperative Group. Christiansen P, et al. Among authors: kroman n. J Natl Cancer Inst. 2011 Sep 21;103(18):1363-72. doi: 10.1093/jnci/djr299. Epub 2011 Aug 31. J Natl Cancer Inst. 2011. PMID: 21881042
196 results